University of Kentucky Pharmacy and Medicine Continuing Education

Faculty Members

UK Faculty

John A. Armitstead, MS, RPH, FASHP
Director, Pharmacy Services, UK HealthCare

Assistant Dean, UK College of Pharmacy

Carrie L. Johnson, PharmD, CDE
Assistant Professor, Pharmacy Practice and Science
Clinical Pharmacist, PharmacistCARE

Russ Judd, PharmD
PY2 Infectious Diseases Specialty Resident, UK Healthcare
Chair, Kentucky Konnection Committee
Co-chair, Residency Recruitment Committee, UK HealthCare Pharmacy Residency Program

Daniel Lewis, PharmD
Therapeutic Drug Monitoring Pharmacy Specialist, Pharmacy Services, UKMC
Adjunct Assistant Professor, Pharmacy Practice and Science Department, UK College of Pharmacy

Craig Martin, PharmD, BCPS
Adjunct Assistant Professor, Pharmacy Practice and Science Department, UK College of Pharmacy
Clinical Pharmacy Specialist-Infectious Diseases, Pharmacy Services, UK HealthCare

Trenika Mitchell, PharmD, BCPS
Lecturer, Pharmacy Practice and Science Department, UK College of Pharmacy
Clinical Staff Pharmacist, UKMC

Amy S. Nicholas, PharmD, CDE
Co-director, PharmacistCARE
Associate Professor, Pharmacy Practice and Science Department, UK College of Pharmacy
Assistant Coordinator, Geriatrics Elective and Nutrition, Non-Prescription and Advanced Therapeutics Courses

Peggy Piascik, RPh, PhD
Associate Professor, Pharmacy Practice and Science Department, UK College of Pharmacy

Kenneth B. Roberts, RPh, PhD, MBA
Dean, UK College of Pharmacy

Frank Romanelli, PharmD, MPH, BCPS
Assistant Dean for Education, UK College of Pharmacy
Associate Professor, Pharmacy Practice and Science Department, UK College of Pharmacy

Associate Professor, Physician Assistant Studies (Joint Appointment), Division of Clinical Sciences, UK College of Allied Health
Clinical Specialist in HIV/AIDS, UKMC

David W. Rudy, MD
Assistant Professor, Medicine, UK College of Medicine

Daniel Wermeling, PharmD, FASHP
Associate Professor, Pharmacy Practice and Science Department, UK College of Pharmacy
Associate Professor (Joint Appointment), Department of Neurology, UK College of Medicine
Neurology Clinical Pharmacy Specialist, Lexington VAMC

Guest Faculty

Peter P. Cohron, RPh, JD
Associate Professor (part-time), UK College of Pharmacy
Attorney, Private Practice
Lexington, Kentucky

Brooke Hudspeth, PharmD
Staff Pharmacist
Kroger Pharmacy
Lexington, Kentucky

Patricia R. Jennings, DrPH, PA-C
Physician Assistant, Jefferson County Health Department STD Clinic
Physician Assistant, UAB HIV/AIDS Clinic and the Birmingham Veterans Administration HIV Clinic
Birmingham, Alabama

Daniel A. Nadeau, MD
Medical Director, HealthReach Diabetes, Endocrine and Nutrition Center at Exeter Health Resources
Exeter, New Hampshire
Assistant Professor, Medicine, Tufts Medical School
Boston, Massachusetts

Needs Statement

This multi-day educational offering is aimed at augmenting the knowledge base and influencing the practices of community and other practicing pharmacists. Community pharmacists are well recognized as the most accessible and affordable health care professional. This visibility and access provides them with unique opportunities to engage patients and influence care.

Educational offerings at the conference are aimed at contemporary and current practical health-related topics. The offerings have been selected with this perspective in mind. The topics are also multi-faceted and cover various disease-based issues (e.g., Men’s Health, STD/HIV Update, Pain Management, Anti-infectives/Fungals, etc.) as well as non-disease-based but practice relevant issues (e.g., Medication Disposal, Pharmacy Law, etc.).

This program will feature a highly innovative American Diabetes Association-recognized, outcomes-based program (PharmacistCARE) which optimizes management of those with diabetes (DiabetesCARE) and hypertension/dyslipidemia (CardioCARE). This program will likely spur other pharmacists to develop their own ADA-recognized programs and drive the improved care of those with diabetes. It will also guide pharmacists to become more involved in recognizing and optimizing the care of patients with components of the metabolic syndrome.

Objectives

Pharmacists

Discuss ethical and legal issues surrounding the use of lethal injection as a means of state-sanctioned execution
Review technical and clinical aspects of the pharmacotherapy involved in lethal injection
Discuss the role of preventive medicine in the aging male
Evaluate new studies and impact on the treatment of benign prostatic hyperplasia
Assess the role of chemoprevention to reduce the risk of prostate cancer
Analyze approaches to improve safety and efficacy in the treatment of erectile dysfunction
Determine how “green” is your pharmacy
Identify steps in identifying ways to minimize the pharmaceutical impact on the environment
Counsel consumers on how to discard unwanted pharmaceuticals
Describe the epidemiology of chlamydia, gonorrhea, HSV and syphilis in the US
Describe the pathogenesis of C. trachomatis, N. gonorrhea and T. pallidum
Discuss the clinical manifestations, including complications and long term sequela of syphilis, HSV, chlamydial and gonococcal infections
Identify common methods used in the diagnosis of syphilis, HSV, chlamydial and gonococcal infections
Describe public health measures for the prevention of STDs
Describe the most recently marketed drug and delivery systems being employed in pain management
Describe the technological advances in development intended to minimize drug abuse from prescription medications
Describe new antimicrobial agents and/or new therapeutic uses of established agents
Discuss recent trends in antimicrobial resistance
Identify the tools essential for effective pharmacist/physician collaboration
Identify the necessary components of a formal collaborative care agreement in Kentucky
Review current dyslipidemia management strategies and discuss the role of lipoprotein parameters other than LDL or non-HDL in lipid management
Discuss the results of the recent ENHANCE trial and how this will affect therapy decisions
Examine new therapies for treating dyslipidemia that are under active development
Discuss the pathogenesis of the influenza virus as well as prevention and treatment of infection
Describe the background and threat of a potential H5N1 influenza pandemic
Describe extended cycle oral contraceptive characteristics including dosing regimen, indications, potential advantages and common adverse effects
Discuss contemporary issues with hormonal contraceptives including the Ortho Evra patch, desogestrel-containing products and efficacy of products in obese patients
Review the epidemiology of H. pylori
Explain the significance of H. pylori in the etiology and pathophysiology of peptic ulcer disease
Discuss diagnostic tests for H. pylori
Compare and contrast therapeutic strategies employed in H. pylori management
Assess state-of-the-art management of Type 2 diabetes with a focus on weight loss and reduction of cardiovascular risk with some focus on optimal nutrition
Review the use of incretin mimetics, metformin and long-acting insulin in treating Type 2 diabetes
Review use of insulin and incretin mimetic pens and related devices
Discuss ways of minimizing side effects of these classes of medications
Discuss the PharmacistCARE Program and nuances of establishing a Medication Therapy Management (MTM) Service
Discuss the outcomes of the PharmacistCARE Diabetes Care Program to date
Discuss new and recent pharmacy-related issues from legislative and administrative sources
Review recent court cases and the legal issues thereof regarding pharmacists and pharmacies

Technicians

Review the drug classes typically employed in state-sanctioned lethal injection
Describe the technical aspects of lethal injection as it is usually accomplished in the US
Discuss the role of preventive therapies in men’s health
Review current medications for the management of BPH and erectile dysfunction
Identify the most commonly encountered STDs in the US
Describe symptoms associated with the most common STDs in the US
Recognize drug classes commonly used to treat STDs
Describe the most recently marketed drug and delivery systems being employed in pain management
Describe the technological advances in development intended to minimize drug abuse from prescription medications
Describe the need for pharmacist/physician collaboration utilizing a diabetes case example
Discuss the value of pharmacists’ collaboration with physicians and other prescribers and the role of each provider
Describe the different types of pens and devices for delivering drug therapy for the management of diabetes
Discuss the overall management of the patient with diabetes, including weight loss and cardiovascular risk reduction
Identify the need for pharmacists to establish Medication Therapy Management (MTM) Services
Review the components needed to establish MTM Services
Discuss new and recent pharmacy-related issues from legislative and administrative sources
Review recent court cases and the legal issues thereof regarding pharmacists and pharmacies

Credit Statement

Pharmacy

The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This program has been assigned ACPE # 022-000-08-109-L03-P, 022-000-08-110-L01-P, 022-000-08-111-L04-P, 022-000-08-112-L02-P, 022-000-08-113-L01-P, 022-000-08-114-L01-P, 022-000-08-115-L04-P, 022-000-08-116-L01-P, 022-000-08-117-L01-P, 022-000-08-118-L01-P, 022-000-08-119-L01-P, 022-000-08-120-L01-P, 022-000-08-122-L03-P, 022-000-08-121-L04-P and will award up to 15 contact hours (1.5 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of credit will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes signing in at registration, attending the entire session for which credit is claimed, completing the activity evaluation and requesting credit online at conclusion of the activity. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

Pharmacy Technician
The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This activity has been assigned ACPE # 022-000-08-109-L03-T, 022-000-08-110-L01-T, 022-000-08-112-L02-T, 022-000-08-113-L01-T, 022-000-08-115-L04-T, 022-000-08-120-L01-T, 022-000-08-122-L03-T, 022-000-08-121-L04-T and will award up to 9 contact hours (0.9 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of credit will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at conclusion of the activity. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

Target Audience

Pharmacists and Pharmacy Technicians

Faculty Disclosure

Faculty presenters of continuing education programs sponsored by the University of Kentucky College of Pharmacy are expected to disclose any real or perceived conflict of interest. Copies of faculty disclosures will be included in the participant program materials or given prior to the lecture.

Football Tickets and Tailgate Party

Football tickets are SOLD OUT.

The COP Alumni & Development Office is hosting a tailgate party on Saturday, October 18, before the football game. Tickets are $15 each.

Cost of Attendance

Registration fees include online educational materials, a continuing education statement of credit, lunch on Friday, breakfast and breaks each day.

By October 10, 2008

Entire Conference - $250.00
Friday Only - $145.00
Saturday Only - $125.00
Sunday Only - $55.00
Pharmacy Law Only - $35.00
Friday & Saturday - $270.00
Saturday & Sunday - $180.00
Guest Lunch Friday - $21.00

After October 10, 2008
Entire Conference - $275.00
Friday Only - $155.00
Saturday Only - $135.00
Sunday Only - $75.00
Pharmacy Law Only - $55.00
Friday & Saturday - $290.00
Saturday & Sunday - $200.00
Guest Lunch Friday - $21.00

Refund Policy

A refund less a $25.00 processing fee will be issued if written notice of withdrawal is received by October 3, 2008. No refund will be granted after that date. Registration may be transferred to another participant.

The Colleges of Pharmacy and Medicine Continuing Education Office reserves the right to cancel or make substitutions in this activity. A full refund will be issued if circumstances warrant cancellation.

Exhibits

Exhibit Opportunity
Friday, October 17 (6-ft skirted table + 2 chairs provided)
• Exhibit Fee - $500
• Non-profit organization - $50

Sponsor Opportunity
• Lunch for 100 – Friday - $1,800
• Silver Meeting Sponsor - $750
• Gold Meeting Sponsor - $1,000

Because sponsors and exhibits make the difference between a good conference and a great one, we encourage your organization to participate at the highest level possible. If you have questions or would like to propose another opportunity for sponsorship, please contact:

Kim Page, Senior Conference Coordinator
University of Kentucky Colleges of Pharmacy and Medicine Continuing Education Office
One Quality Street, 6th Floor
Lexington, KY 40507-1461
(859) 257-5320 ext. 80340 | Fax (859) 323-2920
Kim.page@uky.edu

Accommodations

All sessions will be held at the Crowne Plaza Campbell House Inn, 1375 Harrodsbrug Road, Lexington, KY 40504 (800) 354-9235. A block of sleeping rooms has been reserved at the rate of $139+ tax per night single/double occupancy. Reservation deadline is September 26, 2008. Reservations made after that date will be on a space/rate available basis. Be sure to request the UK College of Pharmacy group rate to receive the conference rate. Visit http://www.thecambellhouse.net for complete hotel information and directions.

2008 Advances in Pharmacy Practice Annual Fall ConferenceOctober 16, 2008 - October 19, 2008